Theriva Biologics, Inc. (TOVX) Files Proxy Statement Ahead of Shareholder Meeting
Filing Details Theriva Biologics, Inc. (AMEX:TOVX) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on June 29, 2026. The Healthcare…
Read more
